Jan 29- The U.S. Food and Drug Administration on Thursday approved two fixed-dose HIV pills that combine protease inhibitors- one made by Bristol-Myers Squibb Co and the other by Johnson& Johnson- both with a boosting agent produced by Gilead Sciences Inc.. Bristol-Myers said its drug, Evotaz, is a once-daily pill containing Reyataz, also known as atazanavir, a...» Read More
Hundreds of people with HIV/AIDS trying to obtain coverage under Obamacare are in danger of being thrown out of their insurance plan.
U2 lead singer Bono and Bank of America CEO Brian Moynihan discuss efforts to fight the global AIDS epidemic and why American citizens should be proud of efforts to combat the disease. The band and BofA are donating money to RED, an organization created to fight AIDS around the world.
Jimmy Fallon, what an extraordinary man, says musician Bono, discussing his upcoming performance on The Tonight Show when Jimmy Fallon makes his debut as the show's host.
Musician Bono discusses his partnership with Bank of America to create funds to fight and prevent AIDS. We have to keep public pressure to get money from government budgets, says Bono.
Bank of America, the Gates Foundation and others will donate money to (RED) for every download of a U2 song during the Super Bowl halftime show.
A communications director lost her job after tweeting an inappropriate comment just before boarding a plane to Africa. CNBC's Michelle Caruso-Cabrera and Bob Pisani share their opinions.
David Williamson, Healthcare Analyst, Motley Fool says the HIV infection cure for the U.S. toddler through early treatment will not work for adults. He explains why.
U.S. regulators approved a new AIDS treatment made by Merck, the first in a new class of drugs aimed at preventing replication of the virus, Merck said on Friday.
This meeting of the world's richest nations may be the most challenging one for the U.S. in years, given the growing power of Russia and China.
Today is World AIDS Day--and it comes at a time when health experts are considering new strategies in an attempt to change the environment of AIDS transmission. The rate of H-I-V infection is growing, with more than four million new cases each year. One biopharmaceutical company whose portfolio includes several HIV treatments--is Gilead Sciences.